Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
phenotype | 0.700 | None | 0.966 | 0 | 0 | 1995 | 2020 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
phenotype | 0.410 | None | 1.000 | 0 | 0 | 2014 | 2018 | ||||||||
|
5-hydroxytryptamine receptor 1A | 0.522 | 0.846 | 0.20 |
|
phenotype | 0.410 | None | 1.000 | 0 | 0 | 2012 | 2012 | ||||||||
|
MEFV innate immuity regulator, pyrin | 0.440 | 0.885 | 1.0E-14 |
|
phenotype | 0.200 | None | 1.000 | 0 | 0 | 2000 | 2019 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
phenotype | 0.200 | None | 1.000 | 0 | 0 | 2009 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
phenotype | 0.200 | None | 0.957 | 0 | 0 | 1998 | 2019 | ||||||||
|
NLR family pyrin domain containing 3 | 0.361 | 0.962 | 8.1E-04 |
|
phenotype | 0.190 | None | 1.000 | 0 | 0 | 2008 | 2019 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
phenotype | 0.180 | None | 0.875 | 0 | 0 | 1999 | 2018 | ||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
phenotype | 0.160 | None | 1.000 | 0 | 0 | 2000 | 2017 | |||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
phenotype | 0.160 | None | 1.000 | 0 | 0 | 2009 | 2019 | ||||||||
|
toll like receptor 4 | 0.321 | 0.962 | 4.6E-09 |
|
phenotype | 0.130 | None | 1.000 | 0 | 0 | 2014 | 2019 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
phenotype | 0.130 | None | 0.667 | 0 | 0 | 2005 | 2018 | ||||||||
|
calcium voltage-gated channel subunit alpha1 A | 0.489 | 0.769 | 1.00 |
|
phenotype | 0.130 | None | 0.667 | 0 | 0 | 2003 | 2019 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
phenotype | 0.120 | None | 1.000 | 0 | 0 | 2009 | 2019 | ||||||||
|
cytotoxic T-lymphocyte associated protein 4 | 0.369 | 0.923 | 0.94 |
|
phenotype | 0.120 | None | 1.000 | 0 | 0 | 2019 | 2019 | ||||||||
|
carnitine palmitoyltransferase 2 | 0.542 | 0.769 | 4.6E-10 |
|
phenotype | 0.120 | None | 1.000 | 0 | 0 | 2005 | 2014 | ||||||||
|
prion protein | 0.445 | 0.923 | 6.3E-04 |
|
phenotype | 0.120 | None | 1.000 | 0 | 0 | 2018 | 2018 | ||||||||
|
NLR family pyrin domain containing 1 | 0.502 | 0.769 | 5.0E-19 |
|
phenotype | 0.120 | None | 1.000 | 0 | 0 | 2016 | 2018 | ||||||||
|
ectodysplasin A | 0.553 | 0.808 | 0.97 |
|
phenotype | 0.120 | None | 1.000 | 0 | 0 | 2018 | 2019 | ||||||||
|
arginine vasopressin | 0.437 | 0.846 | 7.4E-02 |
|
phenotype | 0.120 | None | 1.000 | 0 | 0 | 2018 | 2019 | ||||||||
|
X-linked inhibitor of apoptosis | 0.447 | 0.808 | 0.92 |
|
phenotype | 0.120 | None | 1.000 | 0 | 0 | 2005 | 2011 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 13 | 0.496 | 0.769 | 5.1E-15 |
|
phenotype | 0.120 | None | 1.000 | 0 | 0 | 2004 | 2014 | ||||||||
|
ATPase Na+/K+ transporting subunit alpha 3 | 0.544 | 0.615 | 1.00 |
|
phenotype | 0.120 | None | 1.000 | 0 | 0 | 2016 | 2018 | ||||||||
|
complement factor H | 0.441 | 0.885 | 0.86 |
|
phenotype | 0.120 | None | 1.000 | 0 | 0 | 2008 | 2011 | ||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
phenotype | 0.110 | None | 1.000 | 0 | 0 | 2017 | 2017 |